Oramed Pharmaceuticals Inc. · NASDAQ:ORMP
Gabay Avraham received 209,291 Oramed Pharmaceuticals Inc. shares as an award (Form 4)
Traded Sep 24, 2026 · Filed Sep 25, 2026
On Sep 24, 2026, Gabay Avraham (Chief Financial Officer) received 209,291 Oramed Pharmaceuticals Inc. shares as an award, leaving 881,076 shares. Filed Sep 25, 2026 (Form 4).
- Awarded
- 209,291 shares
- Holding after
- 881,076 shares
- Trading plan
- No
- Role
- Chief Financial Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 24, 2026 | Common Stock | Award | 209,291 | 881,076 | Direct |
Source
Related
- Oramed Pharmaceuticals Inc.
- Gabay Avraham
- Oramed Pharmaceuticals Inc. shareholders
- Form 4 · Gabay Avraham · Oct 2, 2026
- Form 4 · Gabay Avraham · Jul 2, 2026
- Form 4 · Hexter Joshua · Oct 2, 2026
- Form 4 · Kidron Nadav · Sep 25, 2026
- Form 4 · Hexter Joshua · Sep 25, 2026
- Form 4 · Kidron Miriam · Sep 25, 2026
- Schedule 13G/A · Aquamarine Financial (Cayman) Ltd · Aug 14, 2026